In 2020, approximately 40 men and 29 women per 100,000 population died as a result of pneumonia in England and Wales. In every year in the provided time interval the mortality rate was higher among men, although both genders have experienced a general decline in deaths from pneumonia. Regionally, the North West had the highest mortality rate for both genders.

Pneumonia risk groups

The age groups most at risk from pneumonia is undoubtedly the older age groups. In 2021, in England and Wales, pneumonia was the cause of death for approximately 6.2 thousand over 90 year olds, of which 3.6 thousand were women. Furthermore, around 3.5 thousand individuals aged between 80 and 89 years lost their lives due to pneumonia in 2021.

Prevalence of other lung diseases

In England and Wales in 2019, the mortality rate from bronchitis for men was around 57 per 100,000 population, while the rate for women was approximately 44. The mortality rate for bronchitis was higher than pneumonia, this is caused in part by the large decline in the mortality rate of pneumonia since the year 2000.

Between January and August 2020, there has been approximately 48.2 thousand deaths in England and Wales with COVID-19 as an underlying cause. As illustrated in the table, the number of deaths as a result of COVID-19 are much higher than from either pneumonia or influenza. There has been over three times the number of deaths from COVID-19 than pneumonia and influenza so far in 2020. The overall number of confirmed COVID-19 cases in the UK can be found here. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

In 2020, approximately 40 men and 28 women per 100,000 population died as a result of pneumonia in England. The North West had the highest mortality rate for both genders in this year, with 48.48 men per 100,000 population dying from pneumonia and 34.43 women per 100,000.

Over 12 million people in the United States died from all causes between the beginning of January 2020 and August 21, 2023. Over 1.1 million of those deaths were with confirmed or presumed COVID-19.

Vaccine rollout in the United States Finding a safe and effective COVID-19 vaccine was an urgent health priority since the very start of the pandemic. In the United States, the first two vaccines were authorized and recommended for use in December 2020. One has been developed by Massachusetts-based biotech company Moderna, and the number of Moderna COVID-19 vaccines administered in the U.S. was over 250 million. Moderna has also said that its vaccine is effective against the coronavirus variants first identified in the UK and South Africa.

Adjusted odds ratios with 95% confidence interval from multivariable logistic regression model with GEE for the outcome COVID-19 mortality.

Summary of demographics, COVID-19 status, and comorbidity variables of all COVID-19 patients from January 29, 2020–August 16, 2021 in Mexico.